In 31-week, open-label, radiocalcium kinetics study, 33 early postmenopausal women were randomized to treatment with once-daily EVISTA 60 mg, cyclic estrogen progestin. Back to top Clinical Results FDA Approval FDA approval of Evista was based on the results of several clinical trials. The 60 seconds challenge: Add these searches to your Google homepage within 60 seconds simply click here and follow these instructions Receive the latest medical news on your Google homepage. Women were not the treatment assignment from the osteoporosis treatment trial was carried forward to this study. They may be found only after the revista motor enero 2009 drugs have been used by millions of people and for long time. Women with this medical history should have serum triglycerides monitored when taking EVISTA. Among the factors included in the modified Gail model are the following: current age, number of first-degree relatives with breast cancer, number of breast biopsies, age at menarche, nulliparity or age of first live birth.
Full article